A review of the PD-1/PD-L1 checkpoint in bladder cancer:...

  • Main
  • 2016 / 11
  • A review of the PD-1/PD-L1 checkpoint in bladder cancer:...
Urologic Oncology: Seminars and Original Investigations 2016 / 11

A review of the PD-1/PD-L1 checkpoint in bladder cancer: From mediator of immune escape to target for treatment11MPS is an investor in and consultant for Urogen. SAP is consultant and advisor for Vaccinex. The remaining authors have nothing to disclose.

Zhou, Tian C., Sankin, Alexander I., Porcelli, Steven A., Perlin, David S., Schoenberg, Mark P., Zang, Xingxing
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Urologic Oncology: Seminars and Original Investigations
DOI:
10.1016/j.urolonc.2016.10.004
Date:
November, 2016
File:
PDF, 444 KB
english, 2016
Conversion to is in progress
Conversion to is failed